Responses
Clinical/translational cancer immunotherapy
Original research
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
